1. Home
  2. TGL vs RLAY Comparison

TGL vs RLAY Comparison

Compare TGL & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TGL

Treasure Global Inc.

HOLD

Current Price

$7.06

Market Cap

10.7M

Sector

Technology

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$8.15

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGL
RLAY
Founded
2020
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7M
1.5B
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
TGL
RLAY
Price
$7.06
$8.15
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$16.00
AVG Volume (30 Days)
2.5M
2.3M
Earning Date
02-13-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,305,713.00
$8,355,000.00
Revenue This Year
N/A
$20.47
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.51
$1.78
52 Week High
$780.00
$9.04

Technical Indicators

Market Signals
Indicator
TGL
RLAY
Relative Strength Index (RSI) 52.24 53.65
Support Level $5.75 $8.25
Resistance Level $7.78 $8.58
Average True Range (ATR) 1.39 0.46
MACD -0.42 -0.05
Stochastic Oscillator 41.68 33.46

Price Performance

Historical Comparison
TGL
RLAY

About TGL Treasure Global Inc.

Treasure Global Inc has created an online-to-offline e-commerce platform business model that offers consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retail or merchant settings. Its product is an internet application branded as the ZCITY app, which targets consumers by providing personalized deals based on their purchase history, location, and preferences. The Company has two reportable segments: payment processing and e-commerce operation in its ZCITY platform, and customized software development service, and the majority of revenue comes from payment processing and e-commerce operation in its ZCITY platform.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: